Sign in
Taking peoplePhase 4

Study on the Effect of Fecal Microbiota Transplantation on Eradication of Refractory Helicobacter Pylori Infection

Key facts

Who runs it
Sichuan Provincial People's Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
Phase
Phase 4
People taking part
10 people, planned
Started
20 Jul 2026
Expected to end
31 Dec 2026
Type of study
Interventional
Treatments tested
  • transanal fecal bacteria transplant
Record updated
15 July 2026

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (12)Hide the full registry criteria

Who can take part

  • 1. Ages 18-70
  • 2. Hp infection treatment failed ≥4 times with guidelines-recommended therapies
  • 3. Patients with early gastric cancer, peptic ulcer, gastric MALT lymphoma, atrophic gastritis and other diseases requiring the eradication of Hp

Who cannot take part

  • 1. Antibiotics and bismuth were taken within 4 weeks before this treatment; Or had taken PPI, H2 receptor antagonist, P-CAB within 2 weeks prior to treatment
  • 3. Those who are allergic to the investigational drugs used in this test or have contraindications
  • 4. Participated in other drug trials within 3 months before the treatment of this trial
  • 7. Patients with malignant tumors, serious concomitant diseases, severe ulcer bleeding or perforation
  • 5. There are other serious diseases that affect the evaluation of this study at the same time, or they cannot correctly express their own complaints and cannot cooperate
  • 2. Pregnant or lactating women
  • 6. Subjects with dysphagia
  • 8. Patients judged by the investigator to be unsuitable for clinical trials
  • 9. Those who do not want to sign the informed consent for the study

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Helicobacter pylori infection

This trial is currently available in China.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To determine whether regulating the gut microbiota can contribute to the eradication of refractory H. pylori infection.

The group in the trial

  • washed microbiotaTreatment being tested

    Study on the effect of washed microbiota transplantation on eradication of refractory Helicobacter pylori infection.

    Treatment: transanal fecal bacteria transplant

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT07704255, who can take part
Record updated
15 July 2026